Aptitude provides synthetic affinity molecules – a new generation of aptamers with major advantages.

• Expanded target range including nonimmunogenic proteins, peptides, toxins, glycans, drugs, metabolites, small epitopes
• Fully synthetic, highly stable renewable molecules
• Simple and site-specific conjugation and modification
• Rapid development and production completed in weeks
• Unprecedented affinity and specificity
• Differentiate homologous targets or conformational changes
• Bispecificity